Gregor Schulz

983 total citations
19 papers, 792 citations indexed

About

Gregor Schulz is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Gregor Schulz has authored 19 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 11 papers in Oncology and 7 papers in Genetics. Recurrent topics in Gregor Schulz's work include Hematopoietic Stem Cell Transplantation (10 papers), Neutropenia and Cancer Infections (9 papers) and Blood disorders and treatments (4 papers). Gregor Schulz is often cited by papers focused on Hematopoietic Stem Cell Transplantation (10 papers), Neutropenia and Cancer Infections (9 papers) and Blood disorders and treatments (4 papers). Gregor Schulz collaborates with scholars based in Germany, United States and Netherlands. Gregor Schulz's co-authors include Nissi Varki, Alice L. Yu, David A. Cheresh, Ralph A. Reisfeld, Wolfgang Oster, Roland Mertelsmann, Jürgen Frisch, F. Herrmann, A. Lindemann and C. Mueller‐Eckhardt and has published in prestigious journals such as Cancer, The American Journal of Medicine and Pharmacology & Therapeutics.

In The Last Decade

Gregor Schulz

19 papers receiving 753 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregor Schulz Germany 14 365 272 238 217 195 19 792
JN Ihle United States 11 334 0.9× 315 1.2× 102 0.4× 216 1.0× 183 0.9× 16 753
R. Handgretinger Germany 15 222 0.6× 228 0.8× 286 1.2× 109 0.5× 226 1.2× 33 718
Yasutaka Hoshi Japan 12 233 0.6× 291 1.1× 91 0.4× 389 1.8× 140 0.7× 39 737
A Rosolen Italy 19 263 0.7× 366 1.3× 161 0.7× 73 0.3× 252 1.3× 45 956
T Philip France 14 265 0.7× 206 0.8× 248 1.0× 72 0.3× 165 0.8× 46 692
JF DiPersio United States 14 219 0.6× 138 0.5× 60 0.3× 174 0.8× 302 1.5× 24 651
J. Graham Sharp United States 12 250 0.7× 181 0.7× 44 0.2× 255 1.2× 113 0.6× 26 633
Gianni Am Italy 11 338 0.9× 178 0.7× 47 0.2× 527 2.4× 251 1.3× 23 863
Michael Shepard United States 7 380 1.0× 238 0.9× 35 0.1× 105 0.5× 259 1.3× 13 747
Evi Regitz Germany 19 164 0.4× 354 1.3× 140 0.6× 105 0.5× 328 1.7× 46 864

Countries citing papers authored by Gregor Schulz

Since Specialization
Citations

This map shows the geographic impact of Gregor Schulz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregor Schulz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregor Schulz more than expected).

Fields of papers citing papers by Gregor Schulz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregor Schulz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregor Schulz. The network helps show where Gregor Schulz may publish in the future.

Co-authorship network of co-authors of Gregor Schulz

This figure shows the co-authorship network connecting the top 25 collaborators of Gregor Schulz. A scholar is included among the top collaborators of Gregor Schulz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregor Schulz. Gregor Schulz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Glimm, Hanno, Veit M. Hofmann, Reinhard Henschler, et al.. (1998). Efficient Serum-Free Retroviral Gene Transfer into Primitive Human Hematopoietic Progenitor Cells by a Defined, High-Titer, Nonconcentrated Vector-Containing Medium. Human Gene Therapy. 9(6). 771–778. 25 indexed citations
2.
Kalle, Christof von, Hanno Glimm, Gregor Schulz, Roland Mertelsmann, & Reinhard Henschler. (1998). New developments in hematopoietic stem cell expansion. Current Opinion in Hematology. 5(1). 79–79. 19 indexed citations
3.
Bosse, Roland, et al.. (1997). Good manufacturing practice production of human stem cells for somatic cell and gene therapy. Stem Cells. 15(S2). 275–280. 17 indexed citations
4.
5.
6.
Frisch, Jürgen, Arnold Ganser, Dieter Hoelzer, et al.. (1992). Interleukin-3 and granulocyte-macrophage colony-stimulating factor in combination: Clinical implication. Medical and Pediatric Oncology. 20(S1). 34–37. 2 indexed citations
7.
Burdach, Stefan, et al.. (1992). Biology and pharmacology of hematopoietic growth factors. Medical and Pediatric Oncology. 20(S1). 2–9. 6 indexed citations
8.
9.
Büchler, Markus W., Helmut Frieß, C Gebhardt, et al.. (1991). A randomized controlled trial of adjuvant immunotherapy (murine monoclonal antibody 494/32) in resectable pancreatic cancer. Cancer. 68(7). 1507–1512. 69 indexed citations
10.
Ganser, Arnold, A. Lindemann, G. Seipelt, et al.. (1991). Clinical Effects of Recombinant Human Interleukin-3. American Journal of Clinical Oncology. 14. S51–63. 31 indexed citations
11.
Schulz, Gregor, et al.. (1991). Adjuvant therapy with recombinant interleukin-3 and granulocyte-macrophage colony-stimulating factor. Pharmacology & Therapeutics. 52(1). 85–94. 5 indexed citations
12.
Oster, Wolfgang, Jürgen Frisch, Uwe Nicolay, & Gregor Schulz. (1991). Interleukin-3. Biologic effects and clinical impact. Cancer. 67(S10). 2712–2717. 16 indexed citations
13.
Oster, Wolfgang & Gregor Schulz. (1991). Interleukin 3: Biological and clinical effects. The International Journal Of Cell Cloning. 9(1). 5–23. 34 indexed citations
14.
Oster, Wolfgang, F. Herrmann, H. Gamm, et al.. (1990). Erythropoietin prevents chemotherapy-induced anemia: Case report. Annals of Hematology. 60(2). 88–92. 15 indexed citations
15.
Ho, Anthony D., F. del Valle, M. Engelhard, et al.. (1990). Mitoxantrone/high-dose ara-c and recombinant human gm-csf in the treatment of refractory non-hodgkin's lymphoma a pilot study. Cancer. 66(3). 423–430. 29 indexed citations
16.
Herrmann, F., et al.. (1990). Effect of granulocyte-macrophage colony-stimulating factor on neutropenia and related morbidity induced by myelotoxic chemotherapy. The American Journal of Medicine. 88(6). 619–624. 57 indexed citations
17.
Schulz, Gregor, et al.. (1984). Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients.. PubMed. 44(12 Pt 1). 5914–20. 318 indexed citations
18.
Chersi, Alberto, Gregor Schulz, & Richard A. Houghten. (1984). Immunologic and functional characterization of anti-HLA-DR rabbit antibodies induced by synthetic peptides. Molecular Immunology. 21(10). 847–852. 10 indexed citations
19.
Mueller‐Eckhardt, C., et al.. (1978). Studies on the platelet radioactive anti-immunoglobulin test. Journal of Immunological Methods. 19(1). 1–11. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by JN Ihle Breakdown of academic impact, for papers by R. Handgretinger Breakdown of academic impact, for papers by Yasutaka Hoshi Breakdown of academic impact, for papers by A Rosolen Breakdown of academic impact, for papers by T Philip Breakdown of academic impact, for papers by JF DiPersio Breakdown of academic impact, for papers by J. Graham Sharp Breakdown of academic impact, for papers by Gianni Am Breakdown of academic impact, for papers by Michael Shepard Breakdown of academic impact, for papers by Evi Regitz
Rankless by CCL
2026